The American College of Medical Genetics Foundation and Luminex Corporation are together promoting an annual grant for a project promoting safe and effective genetic testing and services. The award will provide $100,000 to a medical genetics professional proposing the winning one-year project beginning on or before September 1.
Project topics may include, but are not limited to economics, education, and standards development in the field of medical genetics. In order to compete for the award, applicants must be ACMG members and have institutional approval to apply for the award. Additionally, the applicant's project must extend for no longer than one year, be performed in the US or Canada, and it may not already be funded from a source outside of the applicant's institution.
Award applications are due Jan. 29. The winner of the ACMGF/Luminex award will be announced at the ACMG annual meeting in Albuquerque on March 24-28.
Population Diagnostics, a developer of molecular diagnostics and personalized medicine companion tests, announced the appointment of Peggy Eis as chief technology officer. In this role she will oversee scale up of the company's causative biomarker discovery platform for common diseases and be in charge of commercialization of PDx's personalized medicine tests. Prior to PDx, Eis was senior director of genome variation at Roche NimbleGen.
Sequenom has appointed Kenneth Buechler and David Pendarvis to its board of directors. Buechler previously was president, CSO, and co-founder of Biosite. Pendarvis is senior VP of organizational development, global general counsel, and secretary of ResMed.